Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly. | Biochem Biophys Res Commun | 2024 | 38714015 | PubTator, text mining | PubMed |
| Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. | Signal Transduct Target Ther | 2024 | 38688914 | PubTator, text mining | PubMed |
| CARMA3 Drives NF-κB Activation and Promotes Intervertebral Disc Degeneration: Involvement of CARMA3-BCL10-MALT1 Signalosome. | Inflammation | 2024 | 38607566 | PubTator, text mining | PubMed |
| Endoscopic ultrasound-guided fine needle biopsy diagnosis of circumferentially extraluminal mucosa-associated lymphoid tissue lymphoma in the transverse colon: a case report. | Clin J Gastroenterol | 2024 | 38607542 | PubTator, text mining | PubMed |
| Blood MALT1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics. | Immun Inflamm Dis | 2024 | 38578002 | PubTator, text mining | PubMed |
| Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved? | Infect Agent Cancer | 2024 | 38575999 | PubTator, text mining | PubMed |
| AI is a viable alternative to high throughput screening: a 318-target study. | Sci Rep | 2024 | 38565852 | PubTator, text mining | PubMed |
| Motor learning- and consolidation-related resting state fast and slow brain dynamics across wake and sleep. | Sci Rep | 2024 | 38553500 | PubTator, text mining | PubMed |
| Role of Melatonin in Viral, Bacterial and Parasitic Infections. | Biomolecules | 2024 | 38540774 | PubTator, text mining | PubMed |
| Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis. | Cell Commun Signal | 2024 | 38519981 | PubTator, text mining | PubMed |
| Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma. | Mol Cancer Ther | 2024 | 38507740 | PubTator, text mining | PubMed |
| MALT1 inhibition suppresses antigen-specific T cell responses. | Cell Immunol | 2024 | 38422979 | PubTator, text mining | PubMed |
| Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene. | Sci Rep | 2024 | 38418651 | PubTator, text mining | PubMed |
| Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma. | J Med Chem | 2024 | 38349664 | PubTator, text mining | PubMed |
| Naturally occurring T cell mutations enhance engineered T cell therapies. | Nature | 2024 | 38326614 | PubTator, text mining | PubMed |
| Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases. | Medicina (Kaunas) | 2024 | 38276058 | PubTator, text mining | PubMed |
| FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of IKZF1/3 and CK1α to Activate p53 and Inhibit NFκB Signaling. | Cancer Res Commun | 2024 | 38265263 | PubTator, text mining | PubMed |
| MicroRNA‑155‑5p affects regulatory T cell activation and immunosuppressive function by targeting BCL10 in myasthenia gravis. | Exp Ther Med | 2024 | 38223327 | PubTator, text mining | PubMed |
| The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. | Cardiovasc Diabetol | 2024 | 38195542 | PubTator, text mining | PubMed |
| The multifaceted interactions between Newcastle disease virus proteins and host proteins: a systematic review. | Virulence | 2024 | 38193514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=8